منابع مشابه
Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?
I nterest in and controversy over the use of bevacizumab (Avastin; Genentech/Roche, South San Francisco, CA) for the treatment of retinopathy of prematurity (ROP) have increased dramatically after the Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity (BEAT-ROP) study. Off-label bevacizumab has been used extensively for age-related macular degeneration (AMD) for more tha...
متن کاملWrong-side/wrong-site, wrong-procedure, and wrong-patient adverse events: Are they preventable?
HYPOTHESIS Wrong-side/wrong-site, wrong-procedure, and wrong-patient adverse events (WSPEs) are devastating, unacceptable, and often result in litigation, but their frequency and root causes are unknown. Wrong-side/wrong-site, wrong-procedure, and wrong-patient events are likely more common than realized, with little evidence that current prevention practice is adequate. DESIGN Analysis of se...
متن کاملWrong Priors
All priors are not created equal. There are right and there are wrong priors. That is the main conclusion of this contribution. I use, a cooked-up example designed to create drama, and a typical textbook example to show the pervasiveness of wrong priors in standard statistical practice.
متن کاملUniversal protocol for preventing wrong site, wrong procedure, wrong person surgery.
q Pre-operative verification process o Purpose: To ensure that all of the relevant documents and studies are available prior to the start of the procedure and that they have been reviewed and are consistent with each other and with the patient’s expectations and with the team’s understanding of the intended patient, procedure, site and, as applicable, any implants. Missing information or discre...
متن کاملAspirin for the primary prevention of stroke and myocardial infarction: ineffective or wrong dose?
A P P A C R G A N U F S A ore than 40 million Americans take aspirin for the primary or econdary prevention of myocardial infarction and stroke, inluding approximately half of all those aged 65 years or more. he daily dose varies from 81 mg (1 baby aspirin) to 325 mg 1 adult aspirin). The efficacy of aspirin for the secondary revention of myocardial infarction and stroke has been valiated by mu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1986
ISSN: 0028-0836
DOI: 10.1038/324404c0